2024 annual financial data

Gain Therapeutics 2024 Financial results

Direct answer

Revenue was 0 USD.

Operating income was -20,350,592 USD and net income was -20,411,191 USD.
Operating cash flow was -18,873,827 USD.

Get free Gain Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-20,350,592 USD
Net income
-20,411,191 USD
Operating cash flow
-18,873,827 USD